Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid vs platelet-rich plasma for macular amyloidosis
IRCT20250630066301N3Phase 4Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of tranexamic acid and platelet-rich plasma in Macular Amyloidosis (2 arms), sponsored by Mashhad University of Medical Sciences. Started Sep 2025; status: completed.
02
Drugs
tranexamic acidplatelet-rich plasma
03
Conditions
Macular Amyloidosis
Beyond the preview
Go deeper on IRCT20250630066301N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250630066301N3.